Functional Characterization of the NF-κB p65 Transcriptional Activator and an Alternatively Spliced Derivative

REFERENCES

• Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NFκB transcription factor. Science 242:540–546.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA- binding activity in an apparently cytoplasmic precursor of the NFκ B transcription factor. Cell 53:211–217.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1989. A 65 kD subunit of active NF-κB is required for inhibition of NF-κB. Genes Dev 3:1689–1698.
   PubMed Web of Science ®Google Scholar
• Baeuerle, P. A., and D. Baltimore. 1991. The physiology of the NF-kappa-B transcription factor. Mol. Aspects Cell. Regul. 6:409–432.
   Google Scholar
• Ballard, D. W., E. Bohnlein, J. W. Lowenthal, Y. Wano, B. R. Franza, and W. C. Greene. 1988. HTLV-1 Tax induces cellular proteins that activate the κB element in the IL-2 receptor alpha gene. Science 241:1652–1654.
   PubMed Web of Science ®Google Scholar
• Bohnlein, E., J. W. Loiwenthal, M. Siekevitz, D. W. Ballard, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear protein(s) regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 53:827–836.
   PubMedGoogle Scholar
• Brownell, E., N. Mittereder, and N. R. Rice. 1989. A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon. Oncogene 4:935–942.
   PubMed Web of Science ®Google Scholar
• Bull, P., K. L. Morley, M. F. Hoekstra, T. Hunter, and I. M. Verma. 1990. The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain. Mol. Cell. Biol. 10:5473–5485.
   PubMedGoogle Scholar
• Busch, S. J., and P. Sassone-Corsi. 1990. Dimers, leucine zippers and DNA binding domains. Trends Genet. 6:36–40.
   PubMed Web of Science ®Google Scholar
• Capobianco, A. J., D. L. Simmons, and T. D. Gilmore. 1990. Cloning and expression of a chicken c-rel cDNA: unlike p59 (v-rel), p68 (c-rel) is a cytoplasmic protein in embryo fibroblasts. Oncogene 5:257–266.
   PubMedGoogle Scholar
• Dexter, T. M., T. D. Allen, and L. G. Lajtha. 1977. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J. Cell. Physiol. 91:335.
   PubMed Web of Science ®Google Scholar
• Dillon, P. J., P. Nelbock, A. Perkins, and C. A. Rosen. 1990. Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent upon their ability to interact with a structured region present in the env gene mRNA. J. Virol. 64:4428–4437.
   PubMedGoogle Scholar
• Dorshkind, K. 1990. Regulation of hemopoiesis by bone marrow stromal cells and their products. Annu. Rev. Immunol. 8:111–137.
   PubMed Web of Science ®Google Scholar
• Felber, B. K., H. Paskalis, C. Kleinman-Ewing, F. Wong-Staal, and G. N. Pavlakis. 1985. The pX protein of HTLV-1 is a transcriptional activator of its long terminal repeat. Science 229:675–679.
   PubMed Web of Science ®Google Scholar
• Fujisawa, J., M. Seiki, T. Kiyokawa, and M. Yoshida. 1986. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc. Natl. Acad. Sci. USA 82:2277–2281.
   Google Scholar
• Gelinas, C., and H. M. Temin. 1988. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters. Oncogene 3:349–355.
   PubMedGoogle Scholar
• Gentz, R., C. H. Chen, and C. A. Rosen. 1989. Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. Proc. Natl. Acad. Sci. USA 86:821–824.
   PubMedGoogle Scholar
• Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor I-kappa-B. Nature (London) 344:678–682.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., A. M. Gifford, L. B. Riviere, P. Tempst, G. P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell 62:1019–1029.
   PubMed Web of Science ®Google Scholar
• Gilmore, T. D., and H. M. Temin. 1986. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 44:791–800.
   PubMed Web of Science ®Google Scholar
• Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044–1051.
   PubMed Web of Science ®Google Scholar
• Grumont, R. J., and S. Gerondakis. 1989. Structure of a mammalian c-rel protein deduced from the nucleotide sequence of murine cDNA clones. Oncogene 4:1–8.
   Google Scholar
• Hannink, M., and H. M. Temin. 1989. Transactivation of gene expression by nuclear and cytoplasmic rel proteins. Mol. Cell. Biol. 9:4323–4336.
   PubMedGoogle Scholar
• Haskill, S., A. A. Beg, S. M. Tompkins, J. S. Morris, A. D. Yurochko, A. Sampson-Johannes, K. Mondal, P. Ralph, and A. S. Baldwin, Jr. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell 65:1281–1289.
   PubMed Web of Science ®Google Scholar
• Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59.
   PubMed Web of Science ®Google Scholar
• Ip, Y. T., R. Kraut, M. Levine, and C. Rushlow. 1991. The dorsal morphogen is a sequence-specific DNA-binding protein that interacts with a long-range repression element in drosophila. Cell 64:439–446.
   PubMedGoogle Scholar
• Kakidani, H., and M. Patshne. 1988. GAL4 activates gene expression in mammalian cells. Cell 52:161–167.
   PubMed Web of Science ®Google Scholar
• Kamens, J., P. Richardson, G. Mosialos, R. Brent, and T. Gilmore. 1990. Oncogenic transformation by v-Rel requires an amino-terminal activation domain. Mol. Cell. Biol. 10:2840–2847.
   PubMedGoogle Scholar
• Kieran, M., V. Blank, F. Logeat, J. Vandekerchove, F. Lottspeich, O. LeBail, M. B. Urban, P. Kourilsky, P. A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell 62:1007–1018.
   PubMed Web of Science ®Google Scholar
• Kolodziej, P. A., and R. A. Young. 1991. Epitope tagging and protein surveillance. Methods Enzymol. 194:508–519.
   PubMed Web of Science ®Google Scholar
• Landschulz, W. H., P. F. Johnson, and S. L. McKnight. 1988. The leucine binding zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240:1759–1764.
   PubMed Web of Science ®Google Scholar
• Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227–229.
   PubMed Web of Science ®Google Scholar
• Leung, K., and G. Nabel. 1988. HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 333:776–778.
   PubMed Web of Science ®Google Scholar
• McLeod, D. L., M. M. Shreeve, and A. A. Axelrod. 1974. Improved plasma culture system for production of erythrocytic colonies in vitro: quantitative assay method of CFU-E. Blood 44:517.
   PubMed Web of Science ®Google Scholar
• Mermod, N., E. A. O'Neil, T. J. Kelly, and R. Tijan. 1989. The proline-rich transcriptional activator of CTF/NF-1 distinct from the replication and DNA binding domain. Cell 58:741.
   PubMed Web of Science ®Google Scholar
• Narayanan, R., and C. A. Rosen. Unpublished data.
   Google Scholar
• Narayanan, R., N. S. Tare, W. R. Benjamin, and U. Gubler. 1989. A sensitive technique to monitor gene transfer and expression in bone marrow stem cells. Exp. Hematol. 17:832–835.
   PubMedGoogle Scholar
• Nolan, G. P., S. Ghosh, H.-C. Liou, P. Tempst, and D. Baltimore. 1991. DNA binding and IκB inhibition of the cloned p65 subunit of NF-κB, a rel related polypeptide. Cell 64:961–969.
   PubMed Web of Science ®Google Scholar
• Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin-1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86:2336–2340.
   PubMed Web of Science ®Google Scholar
• O'Shea, E. K., R. Rutkowski, and P. S. Kim. 1989. Evidence that the leucine zipper is a coiled coil. Science 243:538–542.
   PubMed Web of Science ®Google Scholar
• Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 33:741–748.
   PubMed Web of Science ®Google Scholar
• Rice, N. R., and R. V. Gilden. 1988. The rel oncogene, p. 495–512. In E. P. Reddy et al. (ed.), The oncogene handbook. Elsevier, New York.
   Google Scholar
• Richardson, P., and T. Gilmore. 1991. v-Rel is an inactive member of the Rel family of transcriptional activating proteins. J. Virol. 65:3122–3130.
   PubMed Web of Science ®Google Scholar
• Roth, S., D. Stein, and C. Nusslein-Volhard. 1989. A gradient of nuclear localization of the dorsal protein determines dorsoventral pattern in the drosophila embryo. Cell 59:1189–1202.
   PubMed Web of Science ®Google Scholar
• Ruben, S., H. Poteat, T. H. Tan, K. Kawakami, R. Roeder, W. Haseltine, and C. A. Rosen. 1988. Cellular transcription factors and regulation of IL-2 receptor gene expression by HTLV-1 tax gene product. Science 241:89–91.
   PubMed Web of Science ®Google Scholar
• Ruben, S. M., P. J. Dillon, R. Schreck, T. Henkel, C.-H. Chen, M. Maher, P. A. Baeuerle, and C. A. Rosen. 1991. Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-κB. Science 251:1490–1493.
   PubMedGoogle Scholar
• Ruben, S. M., and C. A. Rosen. 1990. Suppression of signals required for activation of transcription factor NF-κB in cells constitutively expressing the HTLV-1 tax protein. New Biol. 2:894–902.
   PubMedGoogle Scholar
• Rushlow, C. A., K. Han, J. L. Manley, and M. Levine. 1989. The graded distribution of the dorsal morphogen is initiated by selective nuclear transport in drosophila. Cell 59:1165–1177.
   PubMedGoogle Scholar
• Sadowski, I., and M. Ptashne. 1989. A vector for expressing GAL4(1-47) fusions in mammalian cells. Nucleic Acids Res. 17:7539.
   PubMed Web of Science ®Google Scholar
• Saiki, R. K., D. H. Gelfand, S. Stofel, S. J. Scharf, R. Higuchi, G. T. Horn, K. B. Mullis, and H. A. Ehrlich. 1988. Primer- directed enzymatic amplification of DNA with a thermostabile DNA polymerase. Science 239:487–491.
   PubMed Web of Science ®Google Scholar
• Saiki, R. K., S. Scharf, F. Faloona, K. B. Mullis, G. T. Horn, H. A. Ehrlich, and N. Amheim. 1985. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 235:1350–1354.
   Google Scholar
• Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463–5467.
   PubMed Web of Science ®Google Scholar
• Seiki, M., J.-I. Inoue, T. Takeda, and M. Yoshida. 1986. Direct evidence that p40x of human T-cell leukemia virus type I is a trans-acting transcriptional activator. EMBO J. 5:561–565.
   PubMed Web of Science ®Google Scholar
• Short, J. M., J. M. Fernandez, J. A. Sorge, and W. D. Huse. 1988. Lambda Zap: a bacteriophage lambda expression vector with in vivo excision properties. Nucleic Acids Res. 16:7583–7600.
   PubMed Web of Science ®Google Scholar
• Sodroski, J., C. A. Rosen, W. C. Goh, and W. Haseltine. 1984. A transcriptional activator protein encoded by the c-lor region of the human T-cell leukemia virus. Science 226:61–65.
   PubMedGoogle Scholar
• Steward, R. 1987. Dorsasl, an embryonic polarity gene in drosophila is homologous to the vertebrate proto-oncogene, c-rel. Science 238:692–694.
   PubMed Web of Science ®Google Scholar
• Steward, R. 1989. Relocalization of the dorsal protein from the cytoplasm to the nucleus correlates with its function. Cell 59:1179–1188.
   PubMed Web of Science ®Google Scholar
• Struhl, K. 1988. The Jun oncoprotein, a vertebrate transcription factor, activates transcription in yeast. Nature (London) 332:649.
   PubMedGoogle Scholar
• Urban, M., R. Schreck, and P. Baeuerle. 1991. NF-κB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10:1817–1825.
   PubMed Web of Science ®Google Scholar
• Urban, M. B., and P. A. Baeuerle. 1990. The 65-kD subunit of NF-kappa-B is a receptor for I-κB and a modulator of DNA- binding specificity. Genes Dev. 4:1975–1984.
   PubMedGoogle Scholar
• Urban, M. B., R. Schreck, and P. A. Baeuerle. 1991. NF- kappa-B contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J. 10:1817–1825.
   PubMed Web of Science ®Google Scholar
• Whitlock, C. A., and O. N. Witte. 1982. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc. Natl. Acad. Sci. USA 79:3608.
   PubMed Web of Science ®Google Scholar
• Williams, T., A. Admon, B. Luscher, and R. Tijan. 1988. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2:1557.
   PubMed Web of Science ®Google Scholar
• Ziff, E. B. 1990. Transcription factors: a new family gathers at the cAMP response site. Trends Genet. 6:69–72.
   PubMed Web of Science ®Google Scholar